Literature DB >> 15197546

Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark.

Peter Vestergaard1, Lars Rejnmark, Leif Mosekilde.   

Abstract

AIM: To compare the number of patients diagnosed with osteoporosis and osteoporotic fractures in Denmark, with the number of subjects expected to have osteoporosis. SUBJECTS AND METHODS: From the National Hospital Discharge Register, records for all patients diagnosed with osteoporosis and/or with osteoporotic fractures between 1995 and 1999 were retrieved. Based on normal Danish values for BMD, the expected number of subjects aged 50 years or more with osteoporosis according to the WHO definition was calculated.
RESULTS: The estimated prevalence of osteoporosis was 40.8% of women aged >or=50 years and 17.7% among men. The expected annual incidence was 58,658/million inhabitants in women >or=50 years of age and 23,648/million in men >or=50 years. However, the observed incidence was only 4,823 and 862/million per year, respectively (8.2% and 3.6% of the expected). In 1999, a total of 34,691 hip, spine, and forearm fractures were reported in subjects >or=50 years, and of these, 18,566 were potentially attributable to osteoporosis (14,240 fractures in women and 4,326 in men equaling 14,976 and 5,297/million per year). Only 0.3% of men >or=50 years were receiving a bisphosphonate, while 2.2% of women received a bisphosphonate or raloxifene. Among women >or=50 years, 27.7% received hormone replacement therapy.
CONCLUSIONS: Osteoporotic fractures of the hip, spine, and forearm are rather frequent in Denmark, but the diagnosis of osteoporosis is rarely used. It seems that osteoporosis is markedly underdiagnosed and undertreated in Denmark as probably also elsewhere. This may have significant implications for the prevention of osteoporotic fractures.

Entities:  

Mesh:

Year:  2004        PMID: 15197546     DOI: 10.1007/s00198-004-1680-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  27 in total

1.  Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group.

Authors:  A A Ismail; C Cooper; D Felsenberg; J Varlow; J A Kanis; A J Silman; T W O'Neill
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

2.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group.

Authors:  J A Kanis
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

3.  Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.

Authors:  L J Walsh; C A Wong; M Pringle; A E Tattersfield
Journal:  BMJ       Date:  1996-08-10

4.  The Danish National Hospital Register. A valuable source of data for modern health sciences.

Authors:  T F Andersen; M Madsen; J Jørgensen; L Mellemkjoer; J H Olsen
Journal:  Dan Med Bull       Date:  1999-06

Review 5.  Epidemiology of hip fractures.

Authors:  P Kannus; J Parkkari; H Sievänen; A Heinonen; I Vuori; M Järvinen
Journal:  Bone       Date:  1996-01       Impact factor: 4.398

6.  Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study.

Authors:  L Mosekilde; H Beck-Nielsen; O H Sørensen; S P Nielsen; P Charles; P Vestergaard; A P Hermann; J Gram; T B Hansen; B Abrahamsen; E N Ebbesen; L Stilgren; L B Jensen; C Brot; B Hansen; C L Tofteng; P Eiken; N Kolthoff
Journal:  Maturitas       Date:  2000-10-31       Impact factor: 4.342

7.  Epidemiology of distal forearm fractures in Danish children.

Authors:  M Kramhøft; S Bødtker
Journal:  Acta Orthop Scand       Date:  1988-10

Review 8.  Secondary osteoporosis.

Authors:  Emily Stein; Elizabeth Shane
Journal:  Endocrinol Metab Clin North Am       Date:  2003-03       Impact factor: 4.741

9.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.

Authors:  D Marshall; O Johnell; H Wedel
Journal:  BMJ       Date:  1996-05-18

Review 10.  Fracture risk associated with smoking: a meta-analysis.

Authors:  P Vestergaard; L Mosekilde
Journal:  J Intern Med       Date:  2003-12       Impact factor: 8.989

View more
  72 in total

1.  Validation of a case definition for osteoporosis disease surveillance.

Authors:  W D Leslie; L M Lix; M S Yogendran
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Self-perceived facture risk: factors underlying women's perception of risk for osteoporotic fractures: the Risk-Stratified Osteoporosis Strategy Evaluation study (ROSE).

Authors:  M J Rothmann; J Ammentorp; M Bech; J Gram; O W Rasmussen; R Barkmann; C C Glüer; A P Hermann
Journal:  Osteoporos Int       Date:  2014-11-01       Impact factor: 4.507

3.  Cost and health care resource use associated with noncompliance with oral bisphosphonate therapy: an analysis using Danish health registries.

Authors:  J Kjellberg; A D Jorgensen; P Vestergaard; R Ibsen; F Gerstoft; A Modi
Journal:  Osteoporos Int       Date:  2016-07-09       Impact factor: 4.507

4.  Hospitalised osteoporotic vertebral fractures in Spain: analysis of the national hospital discharge registry.

Authors:  C Bouza; T López; M Palma; J M Amate
Journal:  Osteoporos Int       Date:  2007-01-13       Impact factor: 4.507

Review 5.  Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density.

Authors:  S Nayak; D L Edwards; A A Saleh; S L Greenspan
Journal:  Osteoporos Int       Date:  2015-02-03       Impact factor: 4.507

Review 6.  Osteoporosis: now and the future.

Authors:  Tilman D Rachner; Sundeep Khosla; Lorenz C Hofbauer
Journal:  Lancet       Date:  2011-03-28       Impact factor: 79.321

Review 7.  The pathogenesis, treatment and prevention of osteoporosis in men.

Authors:  Leif Mosekilde; Peter Vestergaard; Lars Rejnmark
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

8.  Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect.

Authors:  E Michael Lewiecki
Journal:  Core Evid       Date:  2010-06-15

9.  Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a review.

Authors:  Peter Vestergaard; Susanna Vid Streym Thomsen
Journal:  Int J Womens Health       Date:  2010-08-09

10.  Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Ther Clin Risk Manag       Date:  2009-11-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.